Recombinant Staphylococcus aureus Putative phosphotransferase MW1515 (MW1515)

What is Staphylococcus aureus Putative phosphotransferase MW1515?

MW1515 is a putative exported protein from Staphylococcus aureus identified through screening methods designed to detect proteins likely to be exported to the bacterial cell surface or extracellular environment. As a putative phosphotransferase, it may be involved in phosphate group transfer reactions that could contribute to bacterial metabolism or signaling pathways. The protein was identified in screening studies using gene fusion techniques with alkaline phosphatase reporters to detect exported proteins from S. aureus . As exported proteins represent the interface between the pathogen and host, MW1515 may play important roles in bacterial survival and virulence during infection.

How was MW1515 initially identified and characterized?

MW1515 was identified using a systematic screen for putative exported proteins from S. aureus. Researchers constructed gene fusions between S. aureus DNA and a truncated version of the Escherichia coli phoA gene, which encodes alkaline phosphatase. This methodology allowed identification of recombinants exhibiting alkaline phosphatase activity, indicating the presence of signal sequences directing protein export. The screening approach was based on the rationale that exported proteins are likely the first point of contact between bacteria and host during infection, making them potential therapeutic targets and virulence factors .

What is the significance of studying exported proteins like MW1515 in S. aureus?

Exported proteins in S. aureus are particularly significant for three main reasons:

• They represent the first point of contact between the bacterium and host during infection, making them critical mediators of pathogen-host interactions .

• They often contribute to virulence mechanisms, such as immune evasion, tissue invasion, and nutrient acquisition from the host.

• With increasing antibiotic resistance in S. aureus, identifying virulence factors like exported proteins provides potential alternative therapeutic targets .

S. aureus causes a wide range of infections in humans, from superficial skin infections to serious conditions like endocarditis, septic arthritis, osteomyelitis, bacteremia, and sepsis . Understanding exported proteins like MW1515 could provide insights into these pathogenic processes.

What are the recommended methods for recombinant expression of MW1515?

Based on experimental approaches used for similar S. aureus proteins, recombinant expression of MW1515 can be achieved through the following methodological pipeline:

• Gene Cloning Strategy: Amplify the MW1515 gene from S. aureus genomic DNA using PCR with specific primers containing appropriate restriction sites.

• Expression Vector Selection: For bacterial expression, pET-based vectors in E. coli are commonly used. For mammalian expression studies, vectors like pcDNA can be employed.

• Purification Approach: Express with an affinity tag (His6, GST, or MBP) for simplified purification. This approach has been successful with other S. aureus proteins, such as AdsA, which was expressed as a soluble and affinity-tagged recombinant in E. coli .

• Protein Solubility Enhancement: Codon optimization for the expression host and expression at lower temperatures (16-20°C) can improve solubility of membrane-associated or exported proteins.

• Activity Verification: Develop phosphotransferase activity assays to confirm the functional integrity of the recombinant protein.

What experimental systems are appropriate for studying MW1515 function?

Several experimental systems can be employed to study MW1515 function:

• In vitro Enzymatic Assays: If MW1515 indeed functions as a phosphotransferase, kinetic studies with purified recombinant protein and potential substrates can elucidate its biochemical properties.

• Gene Knockout Studies: Creating MW1515-deficient S. aureus strains and examining phenotypic changes can reveal its biological role. Similar approaches have been utilized for studying other S. aureus virulence factors like AdsA .

• Cell Culture Models: Human cell lines, particularly immune cells like macrophages (U937 MΦ) and monocytes (CD14+ cells), which are targeted during S. aureus infection, can be used to study host-pathogen interactions .

• Animal Infection Models: Mouse models of S. aureus infection, particularly abscess formation models, would be appropriate for studying MW1515's role in pathogenesis, similar to studies of other virulence factors .

• Protein-Protein Interaction Studies: Techniques like pull-down assays, yeast two-hybrid screenings, or crosslinking approaches can identify host or bacterial proteins interacting with MW1515.

How might MW1515 contribute to S. aureus virulence mechanisms?

Based on our understanding of S. aureus pathogenesis, MW1515 could potentially contribute to virulence through several mechanisms:

• Immune Evasion: If MW1515 modifies host substrates through phosphorylation, it might interfere with immune signaling pathways. S. aureus is known to employ various strategies to evade host immune responses, including the secretion of nucleases that disrupt neutrophil extracellular traps (NETs) .

• Nutrient Acquisition: Phosphotransferases can be involved in metabolic pathways that facilitate bacterial survival in nutrient-limited environments during infection.

• Biofilm Formation: Phosphorylation events often regulate bacterial biofilm formation, which contributes to persistence during chronic infections.

• Host Cell Manipulation: Similar to how S. aureus AdsA modulates host cell death through deoxyribonucleoside conversion , MW1515 might modify host substrates to benefit bacterial survival or proliferation.

• Abscess Formation Contribution: S. aureus forms abscesses as a hallmark of infection . MW1515 could potentially influence this process through interactions with host factors.

What are the challenges in studying MW1515 expression during different phases of S. aureus infection?

Researchers face several challenges when investigating MW1515 expression dynamics:

• Temporal Regulation: S. aureus gene expression changes dramatically during different infection phases (adhesion, invasion, abscess formation, persistence). Capturing MW1515 expression at these various stages requires careful experimental design.

• Environmental Responsiveness: Expression might vary based on microenvironmental conditions (pH, oxygen, nutrient availability), necessitating multiple sampling conditions.

• In vivo Detection Limitations: Quantifying protein expression in vivo during infection presents technical challenges, requiring sensitive detection methods or reporter constructs.

• Strain Variability: Different S. aureus clinical isolates may exhibit variable MW1515 expression patterns, requiring analysis across multiple strains.

• Host Factor Influence: Host immune responses might affect MW1515 expression, requiring controls for host genetic background in animal models.

How does MW1515 compare to other putative exported proteins identified in S. aureus?

MW1515 belongs to a broader category of exported proteins in S. aureus, which can be functionally compared based on several parameters:

Screening studies have identified numerous putative exported proteins from S. aureus, some with known functions and others, like MW1515, whose precise roles remain to be fully elucidated .

Could MW1515 be a candidate antigen for S. aureus vaccine development?

MW1515, as a putative exported protein, might be considered for vaccine development based on several considerations:

• Surface Accessibility: If MW1515 is indeed exported and surface-exposed, it would be accessible to antibodies, making it potentially useful as a vaccine antigen.

• Conservation Across Strains: An effective vaccine antigen should be conserved across clinical isolates. The conservation status of MW1515 would need to be assessed across S. aureus strains.

• Immunogenicity: Studies would need to evaluate if MW1515 elicits protective immune responses. Recent S. aureus vaccine approaches have utilized multiple antigens, such as the recombinant five-antigen S. aureus vaccine (rFSAV) being tested in clinical trials .

• Safety Profile: Any vaccine candidate must have a favorable safety profile. The rFSAV has undergone safety testing in phase 2 clinical trials, demonstrating the importance of this assessment .

• Functional Relevance: If MW1515 plays an important role in virulence, neutralizing it through vaccination could potentially reduce S. aureus pathogenicity.

What immunological assays would be appropriate for evaluating MW1515 as a vaccine antigen?

To evaluate MW1515 as a potential vaccine component, the following immunological assessments would be valuable:

• Antibody Response Measurements: ELISA-based quantification of specific antibody titers against MW1515 following immunization, similar to the approaches used in clinical trials of other S. aureus vaccines .

• Opsonophagocytic Activity Assays: Evaluating whether anti-MW1515 antibodies enhance phagocytosis and killing of S. aureus by immune cells, a key protective mechanism against this pathogen .

• T-cell Response Analysis: Characterizing the T-cell response to MW1515 using techniques like ELISpot or flow cytometry to assess cellular immunity.

• Protection Studies in Animal Models: Challenging immunized animals with S. aureus to assess the protective efficacy of MW1515-based immunization, with endpoints including bacterial burden, abscess formation, and survival rates.

• Epitope Mapping: Identifying the immunodominant epitopes of MW1515 to potentially refine vaccine design.

How should researchers address discrepancies in MW1515 function across different experimental systems?

When encountering contradictory data regarding MW1515 function, researchers should:

• Evaluate Experimental Conditions: Differences in pH, temperature, ionic strength, or substrate concentrations can significantly impact phosphotransferase activity and should be standardized.

• Consider Strain Variations: Genetic differences between S. aureus strains might affect MW1515 function or regulation. Sequence the gene from different strains to identify polymorphisms.

• Assess Post-translational Modifications: Phosphotransferases often undergo regulatory modifications that could differ between in vitro and in vivo conditions.

• Validate with Multiple Approaches: Confirm findings using complementary techniques (biochemical, genetic, structural) to build a more reliable understanding of MW1515 function.

• Control for Host Factors: When studying MW1515 in infection models, control for host genetic factors that might influence outcomes, particularly when comparing results across different host species or cell types.

What bioinformatic approaches are useful for predicting MW1515 function and interactions?

Several computational approaches can provide insights into MW1515 function:

• Sequence-based Analysis:

  • Homology searches to identify related proteins with known functions

  • Motif identification to predict functional domains

  • Signal sequence prediction to confirm export status

• Structural Prediction:

  • Homology modeling based on related phosphotransferases

  • Molecular docking to predict substrate binding

  • Molecular dynamics simulations to understand protein flexibility

• Interaction Network Analysis:

  • Predict potential protein-protein interactions based on co-expression data

  • Functional association networks to place MW1515 in context of S. aureus pathogenesis

• Evolutionary Analysis:

  • Conservation analysis across bacterial species

  • Identification of selective pressure on different protein domains

• Integration with Omics Data:

  • Correlate with transcriptomic and proteomic datasets from S. aureus infection models

  • Pathway enrichment analysis to identify biological processes involving MW1515